Gå frakoblet med Player FM -appen!
Why GLP-1 weight loss drugs are catching investor attention
Manage episode 382750782 series 1456832
This week Stanford Brown CEO Vincent O'Neill meets once again with CIO Nick Ryder to discuss:
- The RBA’s widely anticipated rate hike and where to from here?
- Driving factors behind Australia’s higher-than-expected inflation numbers
- Whether geopolitical risks impact portfolio positioning?
- The potential for GLP-1 “wonder drugs” to impact different companies such as Resmed and CSL
Music provided by: Autumn Trumpet Background Corporate by LesFM | https://lesfm.net/ Music promoted by https://www.chosic.com/free-music/all/ Creative Commons CC BY 3.0 https://creativecommons.org/licenses/by/3.0/
103 episoder
Manage episode 382750782 series 1456832
This week Stanford Brown CEO Vincent O'Neill meets once again with CIO Nick Ryder to discuss:
- The RBA’s widely anticipated rate hike and where to from here?
- Driving factors behind Australia’s higher-than-expected inflation numbers
- Whether geopolitical risks impact portfolio positioning?
- The potential for GLP-1 “wonder drugs” to impact different companies such as Resmed and CSL
Music provided by: Autumn Trumpet Background Corporate by LesFM | https://lesfm.net/ Music promoted by https://www.chosic.com/free-music/all/ Creative Commons CC BY 3.0 https://creativecommons.org/licenses/by/3.0/
103 episoder
Alle episoder
×Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.